NASDAQ
Quoin Pharmaceuticals, Ltd. (QNRX) has a free cash flow growth of 4.18% as of Friday, May 29, 2026. This represents a 111.39% increase compared to its 12-month average of -36.70%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.